News

Neurosoft Bioelectronics selected as one of the TOP 100 Swiss Startups

Every year a panel of leading investors and startup experts determine the final ranking from more than 1'000 young Swiss companies. This is a great acknowledgment of our efforts and progress over the past few years to bring a revolutionary technology to patients and address some of the most devastating neurological disorders, by improving the way we interface with the human brain.

Read more

Blog image
blog image

Neurosoft Bioelectronics adds experts in Neuromodulation & Tinnitus to its Advisory Board

Geneva, Switzerland, 9 December 2021 – Neurosoft Bioelectronics SA, a startup developing the first fully-implantable Brain-Computer Interface(BCI)to treat severe tinnitus, announced two new members to its Advisory Board. Prof. Dirk de Ridder and Dr. Christian Hauptmann, two experts in neuromodulation and tinnitus, join the advisory board to shape and guide the technical and clinical development of a fully-implantable BCI to treat severe tinnitus through cortical neuromodulation.

Read more

blog image

Welcome to Olivia Molloy – our new Process Engineer

Olivia has a BSc in Microbiology and Biochemistry from the National University of Ireland, Galway (NUIG). Over the past 6 years, she has gained significant experience in the Medical Device Industry, primarily in the R&D and manufacturing sector of leading MedTech companies such as Medtronic, Boston Scientific, and Baylis. Welcome to the team, Olivia!

Read more

blog image

Neurosoft Bioelectronics selected for the Medlim Fast Track Acceleration Program

We are very pleased to announce that Neurosoft Bioelectronics has been selected to participate in the Medlim Fast Track Acceleration Program. This year the program has selected 9 promising startups developing breakthrough technology in the Cardiovascular, Diabetes, Neurological & Orthopedic fields. Each startup will receive support in bringing their medical devices to the market through workshops, interaction with experts, coaching sessions and a final pitch event with investors.

Read more

blog image

Welcome to Chloé Fattebert – our new Quality Assurance Manager

Chloé holds a BSc in Microengineering from the HES-SO, and has gained significant experience over the past 8 years working in the Medical Device Industry. As a QA/RA consultant, she specialized in audits, regulatory strategy, manufacturing processes, product quality management, and QMS implementation for novel medical devices, including active implantables. She later worked as QA/RA Director in the endodontic field, leading the team in charge of MDR transition, quality & regulatory strategy, product portfolio optimization, device worldwide registration, and Technical Documentation. Welcome to the team, Chloé!

Read more

blog image

Neurosoft Bioelectronics Receives Nearly $3 Million in Funding

Neurosoft Bioelectronics was awarded nearly $3 million, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 through the European Research Council Proof-of-Concept Grant. Additionally, the firm secured a $100,000 convertible note from the Fongit Innovation Fund. Proceeds will fund clinical study and regulatory approval for epilepsy and advance development for tinnitus application.

Read more

blog image

Welcome to Nicolas Gninenko – our new Clinical Neuroscientist

Nicolas holds a MSc in Bioengineering and a PhD in Electrical Engineering from EPFL. During his PhD, Nicolas led the fMRI arm of the NeuroTin clinical trial on chronic tinnitus supported by the Wyss Center. His work focused on the non-invasive modulation of chronic tinnitus through extensive real-time fMRI neurofeedback, allowing to pinpoint novel maladaptive functional interactions in the human brain. Through his expertise with patients, Nicolas will help to foster new efforts towards new treatments for this debilitating condition. Welcome to the team, Nicolas!

Read more

blog image

Neurosoft Bioelectronics featured as Trailblazer in Longevity.Technology's Neurotech Report

We are very proud to be featured in Longevity.Technology's Neurotech Report as one of the 2022/2023 Trailblazers. The report provides a comprehensive overview of the current Neurotechnology Industry and identifies nine emerging companies which are advancing the neurotech field by developing new hardware and software solutions for both invasive or non-invasive applications.

Read more